Author

Pierre Desreumaux 1

1 CHRU Lille, Université Lille 2,Lille ,France

SHORTENING INTERVAL INJECTION OF ADALIMUMAB IS MORE EFFICIENT THAN DOUBLING DOSE IN CROHN'S DISEASE PATIENTS WITH LOSS OF RESPONSE

Nicolas Duveau, Maria Nachury, Medina Boualit, Romain Gerard, Julien Branche, Vincent Maunoury, Pierre Desreumaux, Benjamin Pariente

SPACING OF INFLIXIMAB THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES IN CLINICAL REMISSION: PRELIMINARY RESULTS OF A RETROSPECTIVE MULTICENTRE FRENCH NATIONAL COHORT

Gaspard DUFOUR, Benjamin Pariente, Romain Altwegg, Ludovic Caillo, Jean-Christophe Valats, Michael Bismuth, Jean-François Bourgaux, Laurent Peyrin-Biroulet, Pierre Desreumaux, Philippe Pouderoux, Pierre Blanc, Guillaume Pineton de Chambrun

Specific faecal microbiome features in healthy individuals with higher risk of Crohn's disease onset

Stanislas Mondot, Caroline Chevarin, Marjorie Cornu, Hélène Sarter, Jean-Frédéric Colombel, Guillaume Savoye, Frank Ruemmele, Alexis Mosca, Delphine Ley, Pierre Desreumaux, Corinne Borderon, Laurent Beaugerie, Anthony Buisson, Michael Collins, Boualem Sendid, Nicolas Barnich, Patricia Lepage, Corinne Gower-Rousseau

TROUGH LEVELS AND ANTIBODIES TO USTEKINUMAB ARE NOT CORRELATED TO RESPONSE TO USTEKINUMAB TREATMENT IN CROHN?S DISEASE PATIENTS

Claire Painchart, Séverine Brabant, Nicolas Duveau, Maria Nachury, Pierre Desreumaux, Julien Branche, Romain Gerard, Medina Boualit, Myriam Labalette, Benjamin Pariente

TROUGH LEVELS AND ANTIBODIES TO USTEKINUMAB ARE NOT CORRELATED TO RESPONSE TO USTEKINUMAB TREATMENT IN CROHN’S DISEASE PATIENTS

Claire Painchart, Séverine Brabant, Nicolas Duveau, Pauline Wils, Medina Boualit, Maria Nachury, Julien Branche, Romain Gerard, Pierre Desreumaux, Myriam Labalette, Benjamin Pariente

Item 21 - 25 / 32
1 2
3
4